Mitsuhiro Sakamoto1, Riki Matsumoto1, Jumpei Togawa2, Hirofumi Takeyama3, Yuichiro Hashi4, Katsuya Kobayashi1, Akihiro Shimotake5, Frank Leypoldt6, Klaus-peter Wandinger7, Takayuki Kondo4, Ryosuke Takahashi1, Akio Ikeda5 (1.Kyoto University Graduate School of Medicine, Department of Neurology, 2.National Hospital Organization Kyoto Medical Center, Department of Neurology, 3.Kyoto University Graduate School of Medicine, Department of Respiratory Care and Sleep Control Medicine, 4.Kansai Medical University Medical Center, Department of Neurology, 5.Kyoto University Graduate School of Medicine, Department of Epilepsy, Movement Disorders and Physiology, 6.University Hospital Schleswig-Holstein, Neuroimmunology, Institute of Clinical Chemistry, and Department of Neurology, 7.University Hospital Schleswig-Holstein, Institute of Clinical Chemistry and Department of Neurology)
Session information
Oral Session
[O-25] Epilepsy2
Fri. May 24, 2019 9:45 AM - 11:15 AM Room 2 (Osaka International Convention Center 5F Small Hall)
Chair:Riki Matsumoto(Division of Neurology, Kobe University Graduate School of Medicine)
Toshi Sai1, Kazuma Tsutou1, Keisuke Imai1, Masashi Hamanaka1, Masahiro Itsukage1, Atsushi Yamamoto1, Tetsuya Ioku1, Masanori Chou1, Kanako Menjyo1, Hidekazu Yamazaki2 (1.Department of Neurology, Kyoto First Red Cross Hospital, 2.Department of Neurology and cerebrovascular Treatment, Yokohama Shintoshi Neurosurgical Hospital)
Satoshi Okada1, Kenzo Koizumi1, Makiko Nishina2, Masateru Katayama3, Satoshi Inoue3, Sadao Suga3 (1.Department of Neurology, Ichikawa General Hsopital, Tokyo Dental College, 2.Department of Internal Medicine, Ichikawa General Hospital, Tokyo Dental College, 3.Department of Internal Neurosurgery, Ichikawa General Hospital, Tokyo Dental College)
Taira Uehara1, Takahiko Mukaino2, Jun Yokoyama2, Toshiki Okadome2, Nobutaka Mukae3, Ayumi Sakata4, Jun-ichi Kira2, Shozo Tobimatsu1 (1.Department of Clinical Neurophysiology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 2.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3.Department of Neurosurgery, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 4.Division of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital)
Namiko Henmi1,2, Shuichiro Neshige2,3, Tomoya Chiba1, Kazushiro Takata1, Akio Ikeda4, Ryosuke Takahashi2, Masaru Yokoe1 (1.Japan community health care organization, Hoshigaoka Medical Center, 2.Department of Neurology, Kyoto University Graduate School of Medicine, 3.Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, 4.Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine)
Kazuma Tsuto1, Keisuke Imai1, Masashi Hamanka1, Masahiro Itsukage1, Atsushi Yamamoto1, Toshi Sai1, Masanori Cho1, Kanako Menjo1, Hidekazu Yamazaki2 (1.Department of Neurology and Stroke Treatment, Kyoto First Red Cross Hospital, 2.Department of Neurology and Cerebrovascular Treatment, Yokohama Shintosi Neu rosurgical Hospital, Kanagawa, Japan)